Anthera Pharmaceuticals Inc (ANTH)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Hislop	$5.31	12,500	$66,341.25	19,147	2015-11-13	Filing
Hislop	$5.38	5,000	$26,900.00	19,147	2015-11-11	Filing
Odink	$6.15	1,205	$7,410.75	7,896	2015-10-12	Filing
Orbimed Director	$0.73	1,283,300	$942,070.53	0	2012-06-29	Filing
Orbimed Director	$2.40	1,306,700	$3,140,130.77	1,283,300	2012-03-22	Filing
Orbimed Director	$2.87	125,000	$358,312.50	2,590,000	2012-03-21	Filing
Orbimed Director	$2.90	116,800	$338,638.24	2,715,000	2012-03-20	Filing
Odink Officer	$6.57	2,000	$13,140.00	26,659	2012-03-01	Filing
Truex Officer, Director	$7.84	15,000	$117,600.00	625,125	2012-02-15	Filing
Hislop Officer	$8.20	30,000	$246,000.00	27,967	2012-02-03	Filing
Lowe Officer	$7.66	15,000	$114,900.00	31,151	2012-02-01	Filing
Odink Officer	$7.67	2,000	$15,340.00	21,241	2012-02-01	Filing
Truex Officer, Director	$6.75	15,000	$101,250.00	627,125	2012-01-17	Filing
Odink Officer	$6.51	800	$5,205.28	23,241	2012-01-10	Filing
Odink Officer	$6.50	1,200	$7,800.00	24,441	2012-01-06	Filing
Healy Large Shareholder, Director	$6.23	280	$1,743.00	44,969	2011-12-30	Filing
Healy Large Shareholder, Director	$6.23	4,090	$25,460.25	653,550	2011-12-30	Filing
Healy Large Shareholder, Director	$6.23	20,630	$128,421.75	3,298,684	2011-12-30	Filing
Sofinnova Large Shareholder	$6.23	280	$1,743.00	44,969	2011-12-30	Filing
Sofinnova Large Shareholder	$6.23	4,090	$25,460.25	653,550	2011-12-30	Filing